Skip to main content
en
fr
Search form
Search
Main menu
About us
Our mission
Facts & Figures
Our Strategy
Corporate Governance/ Executive Committee
bioMérieux Worldwide
Our History
Innovation
Institut Mérieux
Responsibility
Our commitments
Responsibility to society
Responsibility to our workforce
Responsibility to the environment
Ethics & Compliance
Sustainable and socially inclusive purchasing
Global Compact
Internal Audit & Risks
FONDATION MÉRIEUX
OUR EMPLOYEE'S SUCCESS
Solutions
Clinical Solutions
Industry Solutions
Product Quality & Safety
Customer Service
Cybersecurity & data privacy
Technical Library
CLINICAL SOLUTIONS
INDUSTRY SOLUTIONS
Expertise
The importance of diagnostics
Clinical diagnostics
Industrial Microbiological Control
Clinical applications
Infectious diseases
COVID-19
Antimicrobial resistance and Healthcare-associated infections
Cardiovascular Emergencies
Personalized medicine
Industrial applications
Agri-food sector
Biopharma & cosmetics sectors
Our technologies, systems and services
Microbiology
Molecular Biology
Immunoassays
Laboratory efficiency
Glossary of Scientific Terms
Education
Antimicrobial Resistance / Antimicrobial Stewardship
Webinars
Educational Materials
External Resources
Sepsis / Bloodstream Infections
Webinars
Educational Tutorials
Educational Materials
External Resources
COVID-19
Webinars
Educational booklets
Investors
The bioMérieux Share
Publications
Regulated Information
Governance
Shareholder area
UNIVERSAL REGISTRATION DOCUMENT
CORPORATE SOCIAL RESPONSIBILITY
Newsroom
Press Releases
Corporate calendar
Media Center
About bioMérieux
bioMérieux announces the CE marking of its molecular biology ARGENE® test for the simultaneous detection of SARS-CoV-2, influenza viruses A and B, and RSV and hMPV viruses
PRESS CONTACTS
Careers
Joining bioMérieux
Corporate culture
Public health mission
International presence
Professional development
Diversity and inclusion
Well-being at work
Compensation and benefits
Job Profiles
R&D
Manufacturing
Supply Chain
Information Systems
Quality
Business
Support Functions
Medical Affairs
HSE
Clinical Affairs and Regulatory Affairs
Contact us
About us
Our mission
Facts & Figures
Our Strategy
Corporate Governance/ Executive Committee
bioMérieux Worldwide
Our History
Innovation
Institut Mérieux
Responsibility
Our commitments
Responsibility to society
Responsibility to our workforce
Responsibility to the environment
Ethics & Compliance
Sustainable and socially inclusive purchasing
Global Compact
Internal Audit & Risks
Solutions
Clinical Solutions
Industry Solutions
Product Quality & Safety
Customer Service
Cybersecurity & data privacy
Technical Library
Expertise
The importance of diagnostics
Clinical applications
Industrial applications
Our technologies, systems and services
Glossary of Scientific Terms
Education
Antimicrobial Resistance / Antimicrobial Stewardship
Sepsis / Bloodstream Infections
COVID-19
Educational booklets
Investors
The bioMérieux Share
Publications
Regulated Information
Governance
Shareholder area
Newsroom
Press Releases
Corporate calendar
Media Center
About bioMérieux
Careers
Joining bioMérieux
Job Profiles
Contact us
Investor Relations
Press Contacts
en
fr
Search form
Search
You are here
Home
Investors
Governance
Status
Investors
The bioMérieux Share
Stock Market Information
Historic Chart
Analysts Coverage
Analysts Consensus
Publications
Calendar
Press Releases
Presentations
Annual Reports
Universal Registration Documents
Regulated Information
Governance
Regulated Agreements
Status
Board Charter
Shareholder area
General Shareholders' Meeting
Participating In The General Shareholder's Meeting
Dividends
Crossing the Thresholds
Status
Download the bioMérieux SA Articles of Association
Updated May 17
th
, 2018
